• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Medicines use review service in community pharmacies in Spain: REVISA project.西班牙社区药店的药物使用审查服务:REVISA 项目。
Int J Clin Pharm. 2021 Jun;43(3):524-531. doi: 10.1007/s11096-020-01158-2. Epub 2020 Sep 29.
2
Characterization of patients' requests and pharmacists' professional practice in oropharyngeal condition in Spain.西班牙口咽疾病患者诉求及药剂师专业实践的特征分析
Int J Clin Pharm. 2015 Apr;37(2):300-9. doi: 10.1007/s11096-014-0053-4. Epub 2015 Feb 24.
3
Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.评估比利时社区药房针对哮喘患者的新药服务的实施保真度。
Res Social Adm Pharm. 2017 Jan-Feb;13(1):98-108. doi: 10.1016/j.sapharm.2016.02.001. Epub 2016 Feb 12.
4
Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.对英格兰社区药房复杂医疗保健干预措施的新药品服务(NMS)的审查。
Res Social Adm Pharm. 2016 Nov-Dec;12(6):966-989. doi: 10.1016/j.sapharm.2015.12.007. Epub 2015 Dec 29.
5
Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes.西班牙社区药房实施药物审查及随访及其取得的成果。
Int J Clin Pharm. 2015 Oct;37(5):931-40. doi: 10.1007/s11096-015-0145-9. Epub 2015 Jun 4.
6
Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.社区药房慢性肾病风险评估服务的患者满意度
Int J Clin Pharm. 2018 Apr;40(2):458-463. doi: 10.1007/s11096-018-0603-2. Epub 2018 Feb 13.
7
Organisational factors associated with safety climate, patient satisfaction and self-reported medicines adherence in community pharmacies.社区药房中与安全氛围、患者满意度及自我报告的药物依从性相关的组织因素。
Res Social Adm Pharm. 2020 Jul;16(7):895-903. doi: 10.1016/j.sapharm.2019.09.058. Epub 2019 Sep 18.
8
A community pharmacist medicines optimisation service for patients with advanced cancer pain: a proof of concept study.社区药剂师为晚期癌症疼痛患者提供药物优化服务:概念验证研究。
Int J Clin Pharm. 2019 Jun;41(3):700-710. doi: 10.1007/s11096-019-00820-8. Epub 2019 Apr 9.
9
Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.在澳大利亚社区药房实施心理健康药物管理干预措施:促进因素与挑战
Res Social Adm Pharm. 2017 Sep-Oct;13(5):969-979. doi: 10.1016/j.sapharm.2017.05.017. Epub 2017 May 29.
10
Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).评估社区药房模式在西班牙加泰罗尼亚地区用于结直肠癌筛查项目的适宜性。
J Oncol Pharm Pract. 2017 Jan;23(1):26-32. doi: 10.1177/1078155215616278. Epub 2016 Jul 9.

引用本文的文献

1
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.欧洲社区药房实践中药物相关问题的识别、分类与记录:一项范围综述
Int J Clin Pharm. 2025 Apr;47(2):247-269. doi: 10.1007/s11096-024-01834-7. Epub 2025 Jan 8.

本文引用的文献

1
Clinical outcomes of community pharmacy services: A systematic review and meta-analysis.社区药学服务的临床效果:系统评价和荟萃分析。
Health Soc Care Community. 2019 Sep;27(5):e567-e587. doi: 10.1111/hsc.12794. Epub 2019 Jun 21.
2
Community pharmacist led medication reviews in the UK: A scoping review of the medicines use review and the new medicine service literatures.英国社区药剂师主导的药物评估:药物使用评估和新药服务文献的范围综述。
Res Social Adm Pharm. 2020 Feb;16(2):111-122. doi: 10.1016/j.sapharm.2019.04.010. Epub 2019 Apr 19.
3
Community-Level Pharmaceutical Interventions to Reduce the Risks of Polypharmacy in the Elderly: Overview of Systematic Reviews and Economic Evaluations.降低老年人多重用药风险的社区层面药物干预措施:系统评价与经济评估概述
Front Pharmacol. 2019 Apr 2;10:302. doi: 10.3389/fphar.2019.00302. eCollection 2019.
4
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.老年人的多药治疗:来自 REPOSI 登记处 10 年经验的教训。
Intern Emerg Med. 2018 Dec;13(8):1191-1200. doi: 10.1007/s11739-018-1941-8. Epub 2018 Aug 31.
5
Community pharmacy Medicines Use Review: current challenges.社区药房药物使用评估:当前挑战
Integr Pharm Res Pract. 2018 Jul 9;7:83-92. doi: 10.2147/IPRP.S148765. eCollection 2017.
6
Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial.瑞士初级保健中患者对药剂师主导的药物审查“多重用药检查”的人文结果及接受度:一项前瞻性随机对照试验
Patient Prefer Adherence. 2018 Jun 19;12:1071-1078. doi: 10.2147/PPA.S160789. eCollection 2018.
7
Community pharmacists' views of using a screening tool to structure medicines use reviews for older people: findings from qualitative interviews.社区药剂师对使用筛查工具构建老年人用药审查的看法:定性访谈结果
Int J Clin Pharm. 2018 Oct;40(5):1086-1095. doi: 10.1007/s11096-018-0659-z. Epub 2018 May 23.
8
Validity of the EQ-5D-5L and reference norms for the Spanish population.EQ-5D-5L 及其西班牙人群参考值的有效性。
Qual Life Res. 2018 Sep;27(9):2337-2348. doi: 10.1007/s11136-018-1877-5. Epub 2018 May 16.
9
The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes.药剂师主导的依从性支持对2型糖尿病患者血糖控制的影响。
Int J Clin Pharm. 2018 Apr;40(2):354-359. doi: 10.1007/s11096-018-0606-z. Epub 2018 Feb 21.
10
Development and utilization of the Medicines Use Review patient satisfaction questionnaire.药物使用评估患者满意度调查问卷的开发与应用
Patient Prefer Adherence. 2017 Oct 20;11:1797-1806. doi: 10.2147/PPA.S146991. eCollection 2017.

西班牙社区药店的药物使用审查服务:REVISA 项目。

Medicines use review service in community pharmacies in Spain: REVISA project.

机构信息

Chair of Health Economics and Rational Use of Drugs, Department of Pharmacology. University of Málaga, Boulevard Louis Pasteur, 32, 29071, Málaga, Spain.

Pharmacoeconomics: Clinical and Economic Evaluation of Pharmaceutical Drugs and Palliative Care, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain.

出版信息

Int J Clin Pharm. 2021 Jun;43(3):524-531. doi: 10.1007/s11096-020-01158-2. Epub 2020 Sep 29.

DOI:10.1007/s11096-020-01158-2
PMID:32996076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8214585/
Abstract

Background Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. Objective The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. Method A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient's medicines use. Main outcome measure Medicines use review-related time and cost, satisfaction and willingness to pay. Results A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). Conclusion Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners.

摘要

背景

社区药房服务在控制与药物使用相关的一些因素方面发挥着重要作用,患者可以从这些服务中受益,以提高他们对药物的依从性和知识,同时减少与药物相关的问题。

目的

REVISA 项目旨在对西班牙社区药房实施药物使用审查服务进行初步研究。

地点

西班牙所有地区的 64 家社区药房。

方法

采用便利抽样的方法,对自愿参与的社区药房进行了初步实施、横断面多中心研究。通过结构化访谈,药剂师可以更好地了解患者的药物使用情况。

主要结果测量

药物使用审查相关的时间和成本、满意度和支付意愿。

结果

共纳入 495 名患者。患者的平均年龄为 66.1 岁,其中女性占 56.4%,平均用药 5.7 种。共评估了 2811 种药物,提出了 550 项转诊建议(29.8%至初级保健)。药剂师在药物使用审查服务中花费的平均时间为 52.8 分钟(与药物使用审查相关的费用为 17.27 欧元)。大多数患者对这项服务表示高度满意(98.5%),并表示愿意为此付费(84%)。

结论

西班牙社区药房的药物使用审查服务可以提供,它似乎可以被患者接受,而且大多数患者表示愿意为此付费。这项服务可能为药剂师和全科医生之间的专业合作提供机会。